CONTRAST-INDUCED NEPHROPATHY
Clinical trials for CONTRAST-INDUCED NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new CONTRAST-INDUCED NEPHROPATHY trials appear
Sign up with your email to follow new studies for CONTRAST-INDUCED NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Low-Dose amlodipine may shield diabetic kidneys from contrast harm
Disease control Not yet recruitingThis early-phase study tests whether giving a low dose of oral amlodipine can help protect the kidneys of diabetic patients in the intensive care unit from damage caused by contrast dye used in imaging procedures. The trial will enroll 40 adults aged 18 to 70 with diabetes and no…
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Phase: EARLY_PHASE1 • Sponsor: Minia University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Can electrolytes predict kidney damage after stroke clot removal?
Knowledge-focused Not yet recruitingThis study looks at whether blood electrolyte levels can predict kidney damage in stroke patients who undergo a clot removal procedure. Researchers will review medical records of 250 adults treated between 2018 and 2026. The goal is to find new ways to identify patients at higher…
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 06:40 UTC